There is evidence that some pharmacological interventions are efficacious in treating substance-use disorders, though their use can depend on the type of substance that is abused. Pharmacological treatments for substance-use disorders include  acamprosate, buprenorphine, disulfiram, LAAM, methadone, and naltrexone. Behavioral interventions
Behavioral interventions also have a fairly strong evidence base in impulse-control disorders. In ADHD, the behavioral interventions of behavioral parent training, behavioral classroom management, and intensive peer-focused behavioral interventions in recreational settings meet stringent guidelines qualifying them for evidence based treatment status. In addition, a recent meta-analysis of evidence-based ADHD treatment found organization training to be a well-established treatment method. Empirically validated behavioral treatments for substance use disorder are fairly similar across substance use disorders, and include behavioral couples therapy, CBT, contingency management, motivational enhancement therapy, and relapse prevention. Pyromania and kleptomania are understudied (due in large part to the illegality of the behaviors), though there is some evidence that psychotherapeutic interventions (CBT, short term counseling, day treatment programs) are efficacious in treating pyromania, while kleptomania seems to be best addressed using SSRIs. Additionally, therapies including CBT, family therapy, and social skill training have shown positive effects on explosive aggressive behaviors. See also
Affect
ADHD
Addiction
Deferred gratification
Drive theory
Emotion
Feeling
Instinct
Impulse control disorder
Sensation seeking
Novelty seeking
Alternative five model of personality

References
Further reading
Evenden, J. L. (21 October 1999). "Varieties of impulsivity". Psychopharmacology. 146 (4): 348–361. doi:10.1007/PL00005481. PMID 10550486. S2CID 5972342. Hollander, E.; Rosen, J. (March 2000). "Impulsivity". Journal of Psychopharmacology. 14 (2_suppl1): S39–S44. doi:10.1177/02698811000142S106. PMID 10888030. S2CID 243171966.
Both sorts of interventions are aimed at improving executive functioning and self-control capacities, with different interventions specifically targeting different aspects of executive functioning like inhibitory control, working memory, or attention. Emerging evidence suggests that brain training interventions may succeed in impacting executive function, including inhibitory control. Inhibitory control training specifically is accumulating evidence that it can help individuals resist temptation to consume high calorie food and drinking behavior. Some have voiced concerns that  the favorable results of studies testing working memory training should be interpreted with caution, claiming that conclusions regarding changes to abilities are measured using single tasks, inconsistent use of working memory tasks, no-contact control groups, and subjective measurements of change. Treatment of specific disorders of impulsivity
Behavioral, psychosocial, and psychopharmacological treatments for disorders involving impulsivity are common. Psychopharmacological intervention
Psychopharmacological intervention in disorders of impulsivity has shown evidence of positive effects; common pharmacological interventions include the use of stimulant medication, selective serotonin reuptake inhibitors (SSRIs) and other antidepressants. ADHD has a well-established evidence base supporting the use of stimulant medication for the reduction of ADHD symptoms. Pathological gambling has also been studied in drug trials, and there is evidence that gambling is responsive to SSRIs and other antidepressants. Evidence based pharmacological treatment for trichotillomania is not yet available, with mixed results of studies investigating the use of SSRIs, though cognitive behavioral therapy has shown positive effects. Intermittent explosive disorder is most often treated with mood stabilizers, SSRIs, beta blockers, alpha agonists, and anti-psychotics (all of which have shown positive effects).